Results 171 to 180 of about 217,964 (360)
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT The 5‐hydroxytryptamine type 4 receptor agonist mosapride is known to modulate esophageal peristalsis and enhance lower esophageal sphincter compliance. However, its impact on oropharyngeal swallowing physiology remains insufficiently characterized.
Shu‐Wei Liang +7 more
wiley +1 more source
Novel Biomolecule‐Infused Gelatin Injectable for Treatment of Recurrent Laryngeal Nerve Injury
The Laryngoscope, EarlyView.Biomolecule‐infused gelatin shows promising nerve regeneration, attenuation of muscle atrophy, and functional electromyography outcomes after recurrent laryngeal nerve injury. This biomolecule cocktail may serve as a possible long‐term treatment for vocal fold paralysis and warrants further research in additional animal models.
Ananya Tadikonda +9 more
wiley +1 more source
Intratumoral Nerve Phased Development: A Promising Therapeutic Target
Medicine Bulletin, EarlyView.ABSTRACT The nervous system has emerged as a critical regulator of tumor biology, engaging in dynamic crosstalk with cancer cells. Although the protumorigenic role of innervation is well established, increasing attention is now directed toward reciprocal influences—how tumors actively shape and remodel local nerve networks within the tumor ...
Xiangxian Che +3 more
wiley +1 more source
Basal Forebrain Volume Predicts Disease Conversion in Prodromal Synucleinopathy
Movement Disorders Clinical Practice, EarlyView.Abstract Background Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal stage of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). The basal forebrain (BF), a key cholinergic structure, is a site of known pathology in later stages of Lewy body disorders.
Lachlan Churchill +5 more
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori +15 more
wiley +1 more source
Botulinum Toxin Efficacy in Upper Limb Tremor: A Systematic Review and Meta‐Analysis
Movement Disorders Clinical Practice, EarlyView.Abstract Background Essential tremor (ET) and dystonic tremor syndrome (DTS) can be treated using botulinum toxin (BoNT) injections. Previous reviews lacked an assessment of the certainty of evidence and focused solely on clinician‐reported outcomes. Additionally, studies have demonstrated interindividual variability in BoNT efficacy. Objective The aim
Iris M. Visser +5 more
wiley +1 more source
On the urea alteration in the α-receptor and the acetylcholine receptor of the vas deferens
, 1970 Kazuhiko Kubota, Shozaburo Sekido
openalex +2 more sources
Movement Disorders Clinical Practice, EarlyView.Abstract Background Anticholinergic medications and botulinum neurotoxin injections are established treatments for dystonia, yet they carry potential side effects and practical challenges. Deep brain stimulation (DBS) is offered in case of poor response to these approaches.
Marcela A. Montiel +5 more
wiley +1 more source
Acetylcholine receptor: ‐SH group reactivity as indicator of conformational changes and functional states [PDF]
, 1977 Benjamín A. Suárez‐Isla +1 more
openalex +1 more source